Acromegaly: Presentation, morbidity and treatment outcomes at a single centre

International Journal of Clinical Practice

Volumn 65, Issue 8, 2011, Pages 896-902

  Anagnostis, P ^a   Efstathiadou, Z A ^a   Polyzos, S A ^a   Adamidou, F ^a   Slavakis, A ^a   Sapranidis, M ^a   Litsas, I D ^a   Katergari, S ^a   Selalmatzidou, D ^a   Kita, M ^a  

^a Aristotle University of Thessaloniki   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADOLESCENT; ADRENAL TUMOR; ADULT; AGED; ARTICLE; CHOLELITHIASIS; DIABETES MELLITUS; DRUG EFFICACY; DYSLIPIDEMIA; ELECTRONIC MEDICAL RECORD; FEMALE; GLUCOSE METABOLISM; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPOPITUITARISM; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MICROADENOMA; MONOTHERAPY; MORBIDITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIOTHERAPY; REMISSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISUAL FIELD DEFECT;

ACROMEGALY; ADENOMA; ADULT; BLOOD GLUCOSE; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79960561155     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02682.x     Document Type: Article

References (27)

1. Melmed S,. Acromegaly. N Engl J Med 2006; 355: 2558-73. (Pubitemid 44917504)
2. Giustina A, Barkan A, Chanson P, et al., Pituitary Society; European Neuroendocrine Association. Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults. J Endocrinol Invest 2008; 31: 820-38.
3. Holdaway IM, Rajasoorya C,. Epidemiology of acromegaly. Pituitary 1999; 2: 29-41.
4. Colao A, Ferone D, Marzullo P, Lombardi G,. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004; 25: 102-52. (Pubitemid 38269977)
5. Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP,. Mortality in acromegaly: a meta-analysis. J Clin Endocrinol Metab 2008; 93: 61-7.
6. Melmed S, Colao A, Barkan A, et al., Acromegaly Consensus Group. Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 2009; 94: 1509-17.
7. Giustina A, Chanson P, Bronstein MD, et al., Acromegaly Consensus Group. A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 2010; 95: 3141-8.
8. Giustina A, Barkan A, Casanueva FF, et al., Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 2000; 85: 526-9. (Pubitemid 32273628)
9. Bex M, Abs R, T'Sjoen G, et al., AcroBel-the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects. Eur J Endocrinol 2007; 157: 399-409. (Pubitemid 350018442)
10. Mestron A, Webb SM, Astorga R, et al., Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 2004; 151: 439-46. (Pubitemid 39430260)
11. Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM, Bates AS,. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab 2004; 89: 1613-7. (Pubitemid 38507910)
12. Kreutzer J, Vance ML, Lopes MB, Laws ER Jr,. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab 2001; 86: 4072-7. (Pubitemid 32848515)
13. Beauregard C, Truong U, Hardy J, Serri O,. Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin Endocrinol (Oxf) 2003; 58: 86-91. (Pubitemid 36098853)
14. Nomikos P, Buchfelder M, Fahlbusch R,. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'. Eur J Endocrinol 2005; 152: 379-87. (Pubitemid 40439490)
15. Biermasz NR, Van Dulken H, Roelfsema F,. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. J Clin Endocrinol Metab 2000; 85: 4596-602. (Pubitemid 32157639)
16. Abosch A, Tyrrel JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB,. Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 1998; 83: 3411-8. (Pubitemid 28500865)
17. De P, Rees DA, Davies N, et al., Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission. J Clin Endocrinol Metab 2003; 88: 3567-72. (Pubitemid 37034496)
18. Fahlbusch R, Honegger J, Buchfelder M,. Surgical management of acromegaly. Endocrinol Metab Clin North Am 1992; 21: 669-92.
19. Shahlaie K, McLaughlin N, Kassam AB, Kelly DF,. The role of outcomes data for assessing the expertise of a pituitary surgeon. Curr Opin Endocrinol Diabetes Obes 2010; 17: 369-76.
20. Colao A, Attanasio R, Pivonello R, et al., Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J Clin Endocrinol Metab 2006; 91: 85-92. (Pubitemid 43069122)
21. Sheppard MC,. Primary medical therapy for acromegaly. Clin Endocrinol (Oxf) 2003; 58: 387-99. (Pubitemid 36390608)
22. Colao A, Cappabianca P, Caron P, et al., Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study. Clin Endocrinol (Oxf) 2003; 70: 757-68.
23. Newman CB, Melmed S, George A, et al., Octreotide as primary therapy for acromegaly. J Clin Endocrinol Metab 1998; 83: 3034-40. (Pubitemid 28500931)
24. Attanasio R, Mainolfi A, Grimaldi F, et al., Somatostatin analogs and gallstones: a retrospective survey on a large series of acromegalic patients. J Endocrinol Invest 2008; 31: 704-10.
25. Ronchi C, Epaminonda P, Cappiello V, Beck-Peccoz P, Arosio M,. Effects of two different somatostatin analogs on glucose tolerance in acromegaly. J Endocrinol Invest 2002; 25: 502-7. (Pubitemid 34661837)
26. Trepp R, Stettler C, Zwahlen M, Seiler R, Diem P, Christ ER,. Treatment outcomes and mortality of 94 patients with acromegaly. Acta Neurochir (Wien) 2005; 147: 243-51.
27. Delaroudis SP, Efstathiadou ZA, Koukoulis GN, et al., Amelioration of cardiovascular risk factors with partial biochemical control of acromegaly. Clin Endocrinol (Oxf) 2008; 69: 279-84. (Pubitemid 352009020)